NEOMED Virologist Weighs in on Anti-Malarial Drugs

April 10, 2020

Last week, the U.S. Food and Drug Administration granted emergency approval to distribute anti-malarial drugs to patients who have been diagnosed with COVID-19.

Angelo DeLucia, Ph.D., an associate professor of molecular virology and cancer biology at Northeast Ohio Medical University, spoke with Spectrum News 1 about using chloroquine phosphate and hydroxychloroquine sulfate to treat COVID-19.

While anti-malarial drugs could be effective, more clinical trials are needed, Dr. DeLucia told Spectrum News 1.

For now, Dr. DeLucia says social distancing is still the most effective option we have.